Clinical Characteristics and Prognoses of Patients With Systemic Lupus Erythematosus Hospitalized for Pulmonary Infections

Objective: To identify factors associated with mortality in SLE patients who were hospitalized for pulmonary infections (PIs).Methods: This single-center retrospective study analyzed the characteristics and risk factors for mortality in 95 SLE patients hospitalized for PIs.Results: Ninety-five SLE p...

Full description

Bibliographic Details
Main Authors: Yanli Yang, Hui Jiang, Chuhan Wang, Nan Jiang, Chanyuan Wu, Shangzhu Zhang, Wei Jiang, Jinmin Peng, Li Weng, Jiuliang Zhao, Qian Wang, Mengtao Li, Bin Du, Yan Zhao, Xiaofeng Zeng
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.732681/full
id doaj-6e2265abcc054da2af9aa940d1eda5df
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Yanli Yang
Yanli Yang
Hui Jiang
Chuhan Wang
Nan Jiang
Chanyuan Wu
Shangzhu Zhang
Wei Jiang
Jinmin Peng
Li Weng
Jiuliang Zhao
Qian Wang
Mengtao Li
Bin Du
Yan Zhao
Xiaofeng Zeng
spellingShingle Yanli Yang
Yanli Yang
Hui Jiang
Chuhan Wang
Nan Jiang
Chanyuan Wu
Shangzhu Zhang
Wei Jiang
Jinmin Peng
Li Weng
Jiuliang Zhao
Qian Wang
Mengtao Li
Bin Du
Yan Zhao
Xiaofeng Zeng
Clinical Characteristics and Prognoses of Patients With Systemic Lupus Erythematosus Hospitalized for Pulmonary Infections
Frontiers in Medicine
systemic lupus erythematosus
pulmonary infection
mortality
risk factor
cardiopulmonary involvement
opportunistic infection
author_facet Yanli Yang
Yanli Yang
Hui Jiang
Chuhan Wang
Nan Jiang
Chanyuan Wu
Shangzhu Zhang
Wei Jiang
Jinmin Peng
Li Weng
Jiuliang Zhao
Qian Wang
Mengtao Li
Bin Du
Yan Zhao
Xiaofeng Zeng
author_sort Yanli Yang
title Clinical Characteristics and Prognoses of Patients With Systemic Lupus Erythematosus Hospitalized for Pulmonary Infections
title_short Clinical Characteristics and Prognoses of Patients With Systemic Lupus Erythematosus Hospitalized for Pulmonary Infections
title_full Clinical Characteristics and Prognoses of Patients With Systemic Lupus Erythematosus Hospitalized for Pulmonary Infections
title_fullStr Clinical Characteristics and Prognoses of Patients With Systemic Lupus Erythematosus Hospitalized for Pulmonary Infections
title_full_unstemmed Clinical Characteristics and Prognoses of Patients With Systemic Lupus Erythematosus Hospitalized for Pulmonary Infections
title_sort clinical characteristics and prognoses of patients with systemic lupus erythematosus hospitalized for pulmonary infections
publisher Frontiers Media S.A.
series Frontiers in Medicine
issn 2296-858X
publishDate 2021-09-01
description Objective: To identify factors associated with mortality in SLE patients who were hospitalized for pulmonary infections (PIs).Methods: This single-center retrospective study analyzed the characteristics and risk factors for mortality in 95 SLE patients hospitalized for PIs.Results: Ninety-five SLE patients had 97 episodes of hospitalization for PIs, and 33 of these episodes (34.02%) led to death. Death from PI was associated with a higher neutrophil count (6.30 vs. 4.201 × 109/L, p < 0.01), immunoglobulin G (6.20 vs. 9.82 g/L, p = 0.01), serum creatinine (126.00 vs. 73.00 μmol/L, p = 0.01), proteinuria (2.99 vs. 0.54 g/day, p < 0.01), cardiopulmonary involvement (57.58 vs. 34.38%, p < 0.05), SLE disease activity index (SLEDAI; 11.00 vs. 6.00, p < 0.05), and opportunistic infections (78.79 vs. 45.31%, p < 0.05). Demographic characteristics, antibody/complements, bacterial infection, and primary treatment before infection (including corticosteroid and immunosuppressants) had no effect. Multivariate analysis indicated cardiopulmonary involvement (HR: 2.077; 95%CI: 1.022–4.220; p = 0.043) and opportunistic infection (HR: 2.572; 95%CI: 1.104–5.993; p = 0.029) were independent risk factors for mortality. High-dose steroid pulse therapy (HR: 0.982; 95%CI: 0.410–2.350; p = 0.982) and first-line immunosuppressant therapy (HR: 1.635; 95%CI: 0.755–3.542, p = 0.212) had no effect on mortality.Conclusion: Cardiopulmonary involvement and opportunistic infection were independent risk factors for mortality for SLE patients hospitalized for PIs. Use of high-dose pulse steroids and or immunosuppressants before hospitalization had no significant effects.
topic systemic lupus erythematosus
pulmonary infection
mortality
risk factor
cardiopulmonary involvement
opportunistic infection
url https://www.frontiersin.org/articles/10.3389/fmed.2021.732681/full
work_keys_str_mv AT yanliyang clinicalcharacteristicsandprognosesofpatientswithsystemiclupuserythematosushospitalizedforpulmonaryinfections
AT yanliyang clinicalcharacteristicsandprognosesofpatientswithsystemiclupuserythematosushospitalizedforpulmonaryinfections
AT huijiang clinicalcharacteristicsandprognosesofpatientswithsystemiclupuserythematosushospitalizedforpulmonaryinfections
AT chuhanwang clinicalcharacteristicsandprognosesofpatientswithsystemiclupuserythematosushospitalizedforpulmonaryinfections
AT nanjiang clinicalcharacteristicsandprognosesofpatientswithsystemiclupuserythematosushospitalizedforpulmonaryinfections
AT chanyuanwu clinicalcharacteristicsandprognosesofpatientswithsystemiclupuserythematosushospitalizedforpulmonaryinfections
AT shangzhuzhang clinicalcharacteristicsandprognosesofpatientswithsystemiclupuserythematosushospitalizedforpulmonaryinfections
AT weijiang clinicalcharacteristicsandprognosesofpatientswithsystemiclupuserythematosushospitalizedforpulmonaryinfections
AT jinminpeng clinicalcharacteristicsandprognosesofpatientswithsystemiclupuserythematosushospitalizedforpulmonaryinfections
AT liweng clinicalcharacteristicsandprognosesofpatientswithsystemiclupuserythematosushospitalizedforpulmonaryinfections
AT jiuliangzhao clinicalcharacteristicsandprognosesofpatientswithsystemiclupuserythematosushospitalizedforpulmonaryinfections
AT qianwang clinicalcharacteristicsandprognosesofpatientswithsystemiclupuserythematosushospitalizedforpulmonaryinfections
AT mengtaoli clinicalcharacteristicsandprognosesofpatientswithsystemiclupuserythematosushospitalizedforpulmonaryinfections
AT bindu clinicalcharacteristicsandprognosesofpatientswithsystemiclupuserythematosushospitalizedforpulmonaryinfections
AT yanzhao clinicalcharacteristicsandprognosesofpatientswithsystemiclupuserythematosushospitalizedforpulmonaryinfections
AT xiaofengzeng clinicalcharacteristicsandprognosesofpatientswithsystemiclupuserythematosushospitalizedforpulmonaryinfections
_version_ 1716864709728141312
spelling doaj-6e2265abcc054da2af9aa940d1eda5df2021-09-29T05:02:56ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2021-09-01810.3389/fmed.2021.732681732681Clinical Characteristics and Prognoses of Patients With Systemic Lupus Erythematosus Hospitalized for Pulmonary InfectionsYanli Yang0Yanli Yang1Hui Jiang2Chuhan Wang3Nan Jiang4Chanyuan Wu5Shangzhu Zhang6Wei Jiang7Jinmin Peng8Li Weng9Jiuliang Zhao10Qian Wang11Mengtao Li12Bin Du13Yan Zhao14Xiaofeng Zeng15Department of Rheumatology and Clinical Immunology, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Peking Union Medical College, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaShanxi Bethune Hospital, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Shanxi Academy of Medical Sciences, Taiyuan, ChinaDepartment of Rheumatology and Clinical Immunology, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Peking Union Medical College, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaDepartment of Rheumatology and Clinical Immunology, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Peking Union Medical College, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaDepartment of Rheumatology and Clinical Immunology, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Peking Union Medical College, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaDepartment of Rheumatology and Clinical Immunology, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Peking Union Medical College, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaDepartment of Rheumatology and Clinical Immunology, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Peking Union Medical College, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaDepartment of Rheumatology and Clinical Immunology, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Peking Union Medical College, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaDepartment of Medicine Intensive Care Unit, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Peking Union Medical College, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaDepartment of Medicine Intensive Care Unit, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Peking Union Medical College, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaDepartment of Rheumatology and Clinical Immunology, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Peking Union Medical College, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaDepartment of Rheumatology and Clinical Immunology, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Peking Union Medical College, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaDepartment of Rheumatology and Clinical Immunology, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Peking Union Medical College, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaDepartment of Medicine Intensive Care Unit, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Peking Union Medical College, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaDepartment of Rheumatology and Clinical Immunology, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Peking Union Medical College, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaDepartment of Rheumatology and Clinical Immunology, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Peking Union Medical College, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, ChinaObjective: To identify factors associated with mortality in SLE patients who were hospitalized for pulmonary infections (PIs).Methods: This single-center retrospective study analyzed the characteristics and risk factors for mortality in 95 SLE patients hospitalized for PIs.Results: Ninety-five SLE patients had 97 episodes of hospitalization for PIs, and 33 of these episodes (34.02%) led to death. Death from PI was associated with a higher neutrophil count (6.30 vs. 4.201 × 109/L, p < 0.01), immunoglobulin G (6.20 vs. 9.82 g/L, p = 0.01), serum creatinine (126.00 vs. 73.00 μmol/L, p = 0.01), proteinuria (2.99 vs. 0.54 g/day, p < 0.01), cardiopulmonary involvement (57.58 vs. 34.38%, p < 0.05), SLE disease activity index (SLEDAI; 11.00 vs. 6.00, p < 0.05), and opportunistic infections (78.79 vs. 45.31%, p < 0.05). Demographic characteristics, antibody/complements, bacterial infection, and primary treatment before infection (including corticosteroid and immunosuppressants) had no effect. Multivariate analysis indicated cardiopulmonary involvement (HR: 2.077; 95%CI: 1.022–4.220; p = 0.043) and opportunistic infection (HR: 2.572; 95%CI: 1.104–5.993; p = 0.029) were independent risk factors for mortality. High-dose steroid pulse therapy (HR: 0.982; 95%CI: 0.410–2.350; p = 0.982) and first-line immunosuppressant therapy (HR: 1.635; 95%CI: 0.755–3.542, p = 0.212) had no effect on mortality.Conclusion: Cardiopulmonary involvement and opportunistic infection were independent risk factors for mortality for SLE patients hospitalized for PIs. Use of high-dose pulse steroids and or immunosuppressants before hospitalization had no significant effects.https://www.frontiersin.org/articles/10.3389/fmed.2021.732681/fullsystemic lupus erythematosuspulmonary infectionmortalityrisk factorcardiopulmonary involvementopportunistic infection